KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,009,028 | +586.3% | 110,639 | +696.2% | 0.00% | – |
| Q2 2023 | $147,020 | -59.6% | 13,896 | +7.9% | 0.00% | -100.0% |
| Q1 2021 | $364,000 | -28.1% | 12,875 | -17.0% | 0.00% | 0.0% |
| Q4 2020 | $506,000 | +57.6% | 15,505 | -15.5% | 0.00% | – |
| Q3 2018 | $321,000 | 0.0% | 18,354 | +4.0% | 0.00% | – |
| Q2 2018 | $321,000 | -39.8% | 17,651 | -37.9% | 0.00% | -100.0% |
| Q1 2018 | $533,000 | – | 28,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |